F230. COMPARISON OF PALIPERIDONE PALMITATE 3-MONTH AND PALIPERIDONE PALMITATE 1-MONTH FORMULATION FOR NEGATIVE SYMPTOMS IN SCHIZOPHRENIA: A PHASE 3 NON-INFERIORITY STUDY

por Mathews, Maju, Gopal, Srihari, Singh, Arun, Gogate, Jagadish, Kim, Edward, Pungor, Katalin
Publicado 2018

Improvement of Negative Symptoms in Schizophrenia with Paliperidone Palmitate 1-Month and 3-Month Long-Acting Injectables: Results from a Phase 3 Non-Inferiority Study

por Gopal, Srihari, Gogate, Jagadish, Pungor, Katalin, Kim, Edward, Singh, Arun, Mathews, Maju
Publicado 2020

Telehealth-Based Psychoeducation for Caregivers: The Family Intervention in Recent-Onset Schizophrenia Treatment Study

por Mueser, Kim T, Achtyes, Eric D, Gogate, Jagadish, Mancevski, Branislav, Kim, Edward, Starr, H Lynn
Publicado 2022

Montgomery‐Åsberg Depression Rating Scale factors in treatment‐resistant depression at onset of treatment: Derivation, replication, and change over time during treatment with esket...

por Borentain, Stephane, Gogate, Jagadish, Williamson, David, Carmody, Thomas, Trivedi, Madhukar, Jamieson, Carol, Cabrera, Patricia, Popova, Vanina, Wajs, Ewa, DiBernardo, Allitia, Daly, Ella J.
Publicado 2022